BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20844060)

  • 1. Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies.
    Katzmann JA; Stankowski-Drengler TJ; Kyle RA; Karen SL; Snyder MR; Lust JA; Dispenzieri A
    Clin Chem; 2010 Dec; 56(12):1899-900. PubMed ID: 20844060
    [No Abstract]   [Full Text] [Related]  

  • 2. Heavy/Light-chain analysis of monoclonal gammopathies.
    Keren DF
    Clin Chem; 2009 Sep; 55(9):1606-8. PubMed ID: 19589841
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis.
    Napodano C; Pocino K; Gulli F; Colacicco L; Santini SA; Zuppi C; Basile U
    J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27424526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraproteinemia and serum protein electrophoresis interpretation.
    Raj S; Guha B; Rodriguez C; Krishnaswamy G
    Ann Allergy Asthma Immunol; 2019 Jan; 122(1):11-16. PubMed ID: 30579431
    [No Abstract]   [Full Text] [Related]  

  • 7. Three Patients with an Unusual Pattern on Urine Immunofixation.
    Schiemsky T; Wils J; Hoet K; Poesen K
    Clin Chem; 2016 Oct; 62(10):1412-3. PubMed ID: 27683595
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies.
    Katzmann JA; Snyder MR; Rajkumar SV; Kyle RA; Therneau TM; Benson JT; Dispenzieri A
    Clin Chem; 2011 Dec; 57(12):1687-92. PubMed ID: 21980167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine.
    Barnidge DR; Krick TP; Griffin TJ; Murray DL
    Rapid Commun Mass Spectrom; 2015 Nov; 29(21):2057-60. PubMed ID: 26443406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint.
    Smith JD; Raines G; Schneider HG
    Clin Chem Lab Med; 2016 Jun; 54(6):967-71. PubMed ID: 26677889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point.
    Pretorius CJ
    Clin Chem Lab Med; 2016 Jun; 54(6):963-6. PubMed ID: 26574893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies.
    Holding S; Spradbery D; Hoole R; Wilmot R; Shields ML; Levoguer AM; Doré PC
    Clin Chem Lab Med; 2011 Jan; 49(1):83-8. PubMed ID: 20961192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HevyLite™ - a new method for detection of monoclonal immunoglobulins].
    Radocha J
    Vnitr Lek; 2015 Jan; 61(1):13-4. PubMed ID: 25989631
    [No Abstract]   [Full Text] [Related]  

  • 15. Two-dimensional electrophoretic analysis of immunoglobulin patterns in monoclonal gammopathies.
    Goldfarb MF
    Electrophoresis; 1992 Jul; 13(7):440-4. PubMed ID: 1425557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest and limit of a free light chain immunoassay in serum and urine for the diagnosis and the follow-up of monoclonal dysglobulinemia].
    Lopez J; Dauwalder O; Joly P; Dimet I; Bienvenu J; Bernon H
    Ann Biol Clin (Paris); 2006; 64(3):287-97. PubMed ID: 16698567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory characterizations on 2007 cases of monoclonal gammopathies in East China.
    Wang H; Gao C; Xu L; Yang Z; Zhao W; Kong X
    Cell Mol Immunol; 2008 Aug; 5(4):293-8. PubMed ID: 18761817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin heavy chain/light chain pairs (HLC, Hevylite™) assays for diagnosing and monitoring monoclonal gammopathies.
    Kraj M
    Adv Clin Exp Med; 2014; 23(1):127-33. PubMed ID: 24596015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
    Levinson SS
    Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: correlation with 24-hr urinary light-chain excretion.
    Alyanakian MA; Abbas A; Delarue R; Arnulf B; Aucouturier P
    Am J Hematol; 2004 Apr; 75(4):246-8. PubMed ID: 15054820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.